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Abstract
Antigen-specific, CD8+, cytolytic T lymphocytes (CTLs)
could potentially provide resistance to several infectious and
malignant diseases. However, the cellular requirements for
the generation of specific CTLs in human lymphocyte cultures are not well defined, and repetitive stimulation with
antigen is often required. We find that strong CD8+ CTL
responses to influenza virus can be generated from freshly
isolated blood T cells, as long as dendritic cells are used as
antigen presenting cells (APCs). Small numbers of dendritic
cells (APC:T cell ratio of 1:50-1:100) induce these CTL responses from most donors in 7 d of culture, but monocytes
are weak or inactive. Whereas both dendritic cells and monocytes are infected with influenza virus, the former serve as
effective APCs for the induction of CD8+ T cells while the
latter act as targets for the CTLs that are induced. The strong
CD8+ response to influenza virus-infected dendritic cells is
accompanied by extensive proliferation of the CD8+ T cells,
but the response can develop in the apparent absence of
CD4+ helpers or exogenous lymphokines. CD4+ influenza
virus-specific CTLs can also be induced by dendritic cells,
but the cultures initially must be depleted of CD8+ cells.
These findings should make it possible to use dendritic cells
to generate human, antigen-specific, CD8+ CTLs to other
targets. The results illustrate the principle that efficient T
cell-mediated responses develop in two stages: an afferent
limb in which dendritic cells are specialized APCs and an
efferent limb in which the primed T cells carry out an immune response to many types of presenting cells. (J. Clin.
Invest. 1994. 94:797-807.) Key words: influenza virus * dendritic cells * CD8+ T cells * cytotoxic T lymphocytes * vaccines

Introduction
The potential role of CD8+, cytolytic T lymphocytes' (CTLs)
in resistance to infectious and malignant diseases has been reemAddress correspondence to Nina Bhardwaj, Laboratory of Cellular
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phasized by recent developments. Antigen-specific CTLs are
recognized as a possible defense mechanism in infection with
HIV-1 (1-3), cytomegalovirus (4), and in malaria (5). Antigens
that are recognized by melanoma-specific CTLs have also been
identified by Van der Bruggen et al. (6) and Brichard et al. (7).
These studies document the specificity of CTLs that recognize
clinically important targets. Less is understood about the initial
generation of these CTLs, however.
As in most T cell responses, the precursors for active CTLs
are quiescent lymphocytes that must be induced to expand clonally and develop effector functions. For CTL activation to occur,
not only must antigens be presented as peptide fragments on
MHC products, but the antigen-MHC complexes must also be
introduced on cells with the requisite accessory functions that
lead to T cell growth and cytolytic activity. There is evidence,
primarily from the studies of killer cells to transplantation antigens, that an effective way to induce human CTLs is to present
antigens on dendritic cells (8). Dendritic cells are specialized
accessory cells for the initiation of many T cell-dependent
immune responses (for review see reference 9).
Here we have used dendritic cells to stimulate virus-specific
CTLs from human blood. The model we chose to study was
influenza. Improved mechanisms for prophylaxis and therapy
are needed in influenza, because control of the respiratory infection is not readily achieved through current approaches to vaccination. For example, presently available vaccines are not designed to induce killer cells but instead boost antibody responses
to viral antigens that undergo antigenic drift and shift (10). It
is known that dendritic cells are a component of the alveolar
septae and airway epithelium of the lung (11, 12) and that the
appearance of influenza virus-specific CTLs is associated with
a more rapid clearance of virus from nasal washings (13). Influenza virus is also the agent used to dissect the different pathways
for antigen presentation and analyze the specificity of CTLs.
Townsend and associates (14, 15) realized that viral proteins
were processed in the cytoplasm and presented as peptides in
association with class I MHC products of the infected cell.
Morrison et al. (16) used influenza virus to distinguish the two
pathways for antigen presentation to CTLs. One emanates from
acidic endocytic vesicles and leads to presentation on MHC
class II to CD4+ CTLs; the other emanates from a nonacidic
biosynthetic compartment for presentation on MHC class I to
CD8+ CTLs. The CTLs that have been the subject of work in
humans are usually generated from unseparated blood mononuclear cells and/or repeated stimulation of responding lymphocytes with exogenous IL-2 and viral antigens (4, 5, 13, 14, 1722). For example, Carreno et al. (17) used repeatedly stimulated
human blood cells in their elegant mapping studies of influenza
peptides that are presented to CTLs. In this study, we identify
an effective accessory cell system to generate human influenzaspecific killer cells.
We show that influenza A virus establishes a nontoxic infecCD4-independent Human Antiviral Cytolytic T Lymphocytes
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tion of human dendritic cells and that these infected dendritic
cells induce the development of strong virus-specific CTLs
within 7 d. Three features of the response will be stressed: both
strong CD8+ T cell proliferation as well as CTL activity are
evident, the killer cells once generated recognize and kill infected MHC class I-matched monocytes, and no exogenous
cytokines or CD4+ helpers are required.

In some cases, the NH4Cl was added throughout the culture period,
which was generally 24 h.

Induction of influenza-specific CTL

Culture medium

1 X 106 purified T cells were cultured in 24-well plates (Costar, Cambridge, MA) with graded doses of influenza virus-infected or uninfected
APCs, in a total volume of 1.1 ml. After 7 d of culture, the cells were
harvested and distributed in varying numbers to 96-well microtiter plates
[100 Al per well]. CTL activity was measured using a 5"Cr-release assay
with infected or uninfected syngeneic monocytes as targets. 1 X 104
targets in a volume of 50 jld were added to each well to generate E:T
ratios ranging from 1:1 to 100:1.

RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with
100 yg/ml gentamicin, 5% human serum, and 10 mM Hepes buffer.

SJCr release assay

Methods

Blood mononuclear cells
In most experiments, buffy coats served as sources of PBMCs and
were obtained from the New York Blood Center (New York, NY).
Blood donors were also healthy volunteers who were HLA typed and
selected for MHC class I mismatch. PBMCs were separated into T cellenriched (ER+) and T cell-depleted fractions (ER-) as previously
described (23).
T cells. ER+ cells were first depleted of monocytes by panning on
dishes coated with human gamma globulin (24). MHC class 11+ and
natural killer (NK) cells (CD16+ and CD1 lb+) were depleted by coating with mAbs 9.3C9 (ATCC;HB 180), and 3G8 (gift of Dr. Jay Unkeless) and OKMI (ATCC;CRL 8026), respectively, followed by panning
on petri dishes coated with goat anti-mouse IgG (8). The resulting T
cell population contained < 2-3% of contaminating MHC class 11+
and NK cells, as monitored by cytofluorography. In some experiments,
T cells were enriched for CD4+ or CD8+ cells by incubation with
Leu 2 or Leu 3 mAbs, respectively, followed by panning as above.
CD4+ and CD8+ cells were > 95% pure when evaluated by staining
with PE-conjugated Leu 2 or Leu 3 (Becton Dickinson & Co., Mountain
View, CA), both before and after the culture period that was used to
generate influenza responses.
APC populations. Monocytes were obtained from ER- cells by
adhering them onto plastic dishes for 60-90 min and dislodged by
pipetting. Nonadherent cells were subsequently used for purification of
B cells and dendritic cells, as described previously (24, 25). Residual
monocytes were first removed by panning on gamma globulin-coated
plates (24). The ER-, FcR- cells proved to be adequately enriched in
the dendritic cells that are needed as APCs for strong CTL responses.
However, to further enrich the dendritic cells, and the potency of the
APCs, ER-, FcR- cells were layered onto 14% metrizamide gradients
(25). After sedimentation, dendritic cells localize to the low density
interface, whereas B cells and NK cells are enriched in the high density
interface. Dendritic cell purity was 50-70% with contaminants being
B cells, NK cells, and a few T cells.

Virus preparation
Influenza virus strain PR8 (A/Puerto Rico/8/34) was kindly provided
by Dr. Peter Palese (Mount Sinai School of Medicine, New York) in
the form of infectious allantoic fluid. Virus was grown up and purified
as previously described (26). Virus stocks were replenished from seed
virus by Spafas Inc. (Storrs, CT) and stored in liquid nitrogen (virus
stock: 20,000 HAU/ml). Virus titers were determined using a hemagglutination assay, as previously described (26).

Infection of cells
APCs and target cells were washed out of medium containing serum
and resuspended in RPMI at 0.5-1 x 107 cells/ml. Virus was added at
a final concentration of 1,000 HAU PR8/ml and incubated for 60 min
at 37°C. This dose is saturating for the induction of influenza-specific
CTLs. To determine whether influenza infection proceeded through an
acidic compartment in APCs, the cells were incubated in 10 mM NH4Cl
for 30 min before adding virus and throughout the subsequent infection.
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Monocytes were obtained from ER- cells by adhering them onto plastic
dishes for 60-90 min and dislodged by pipetting. 1 x 107 monocytes
were cultured in 10 ml volumes in 60-ml Teflon beakers (Savillex Corp.,
Minnetonka, MN) until use as targets in the CTL assay (27). For 5"Cr
labeling and infection, cells were collected on ice, washed free of serum,
and brought up to 1 x 107/ml in RPMI. 400 yCi Na51CrO4 (1 mCi/ml
sterile stock; New England Nuclear, Boston, MA) was added per 1
x 10' monocytes. They were simultaneously infected with 1,000 HAU
PR8/ml for 1 h at 370C. The targets were washed four times and resuspended at 2 x 105/ml, after which 50 sl was aliquoted to each well
containing effector T cells. Spontaneous and total release samples were
prepared by adding the targets to wells containing RPMI alone or a
final concentration of 0.33% SDS, respectively. The plates were centrifuged for 2 min at 15 g and incubated for 5 h at 370C. At the termination
of the assay, the supernatant was collected with absorption cartridges
using a harvesting press (Skatron Instruments Inc., Sterling, VA) and
counted in a gamma counter. Percent specific 5"Cr release was calculated
from the following formula: 100 x [(Release by CTL - spontaneous
release)/(Total release - spontaneous release)]. Spontaneous release was
15-25% of the total release.

FACS analysis of cell populations and cell sorting
After culture with uninfected or virus-infected APCs, T cells were phenotyped by staining with Simultest CD4-FITC/CD8-PE or Simultest
control (Becton Dickinson) and analyzed on a FACScan (Becton-Dickinson). In some experiments, T cells were separated into CD4+ and
CD8+ subsets by sorting on a FACStar Plus (Becton Dickinson).
1 x 107 cells were stained with 20 Al of Simultest CD4-FITC/CD8PE (Becton Dickinson) for 45 min at 4°C, washed three times, and
sorted. CD4+ cells were collected as FITC+ cells whereas CD8+ cells
were PE+. Contamination of CD4+ cells with CD8+ cells or vice versa
was < 1%. Sorted populations were stained again after a period of 7 d
and did not demonstrate any change in their CD4/CD8 phenotype. The
antibodies did not appear to block function because purified populations
could respond to influenza virus-infected APCs (see Results).

Detection of influenza virus infection by

immiunohistochemistry
Cytospins of various cell populations were prepared using a Cytospin
2 centrifuge (Shandon, Inc., Pittsburgh, PA). Slides were fixed in acetone
for 5 min at room temperature and then incubated in hybridoma superuatant for 45 min. The mAbs to influenza virus proteins were kindly
provided by Dr. J. Yewdell, National Institutes of Health, and included
anti-NP (H16-,10-4R5; ATCC HB65) and anti-HA (H28E23 and
H17L2). The cytospins were washed several times with PD/1% BSA,
and incubated with 1:200 dilution of biotinylated goat anti-mouse Ig
(Boehringer Mannheim Biochemicals, Indianapolis, IN), for 45 min,
followed by a horseradish peroxidase (HRP)-biotin-avidin complex
(ABC kit; Vector Laboratories, Inc., Burlingame, CA) for 30 min. Nonbound HRP was then washed off, and the HRP reaction product was
developed with H202 and diaminobenzidine tetrahydrochloride (Polysciences, Warrington, PA).

Lymphocyte proliferation assay
After infection with influenza virus, APCs were added in graded doses
to 1 x 105 T cells in 96-well flat-bottomed plates (Costar). Uninfected
APCs served as controls. Proliferation was determined on days 5-6
with the addition of 4 MCi/ml of [3H]TdR for 12-16 h to triplicate
microwells (mean cpm).

Results
Influenza virus uptake and infection in human dendritic cells.
There is considerable evidence, primarily in mouse cell cultures,
that dendritic cells effectively present viral antigens to T cells
(26, 28-30). Murine dendritic cells can be infected by influenza
virus and elicit potent CTL responses (26, 29). The responses
are dependent upon the synthesis of endogenous viral proteins
(26). We wished to determine the extent to which human dendritic cells could be infected with influenza virus. Dendritic
cells were isolated from buffy coat preparations as previously
described and pulsed with live influenza virus for 1 h in serumfree medium. After multiple washes, immunohistochemistry
was used to detect two viral proteins, NP and HA, within the
cell, from 1 to 16 h after infection (Fig. 1). In addition, dendritic
cells were compared with macrophages isolated from the same
donor.
Dendritic cells failed to stain with isotype-matched antibody
OKT8 (Fig. 1 A) but stained intensely with mAb to MHC class
II (Fig. 1 B). At 16 h after infection, NP staining was primarily
localized to the nucleus of dendritic cells, although there was
clearly a cytoplasmic distribution in addition (Fig. 1 C). A
diffuse distribution of HA, consistent with endogenous viral
protein synthesis, was evident (Fig. 1, D and E). Greater than
90% of the dendritic cells were infected by these criteria, with
a viability of > 90%. The NP and HA patterns of staining at
16 h after infection indicate extensive synthesis of viral proteins
in the dendritic cells. Uninfected dendritic cells did not stain
with any mAbs for viral-specific proteins (data not shown).
After just 1 h of infection, dendritic cells expressed HA
primarily in a granular pattern, suggesting that the virus is first
contained within endocytic vacuoles (Fig. 1 F). Evidence of
viral protein synthesis was also apparent in that there was diffuse cytoplasmic staining of a few cells at this early time point
(Fig. 1 F, black arrows). Pretreatment of dendritic cells with
NH4Cl before, during, and after a virus pulse blocked infection,
i.e., few cells (< 2%) stained with either anti-HA or anti-NP
mAbs (data not shown). These findings confirm that influenza
requires an acidic compartment to deliver its genome to the
cytoplasm and engage in viral-specific protein synthesis. Macrophages were also highly susceptible to infection with influenza.
The degree of infection was generally > 70% (Fig. 1, G and
H). After overnight incubation following infection, many cells
died and appeared to be phagocytosed by viable macrophages
(Fig. 1 G, black arrow). In contrast, dendritic cells showed no
change in viability for up to 2 d after infection.
Lymphocytes also were examined by immunolabeling for
their ability to be infected by influenza virus, but none appeared
to be as infected as dendritic cells. B cells and T cells were not
susceptible to infection as assessed by staining with anti-HA
and NP mAbs. T cell blasts generated with superantigens had
a low level of infection ( 10-30% of the -total T cell preparation),
whereas EBV-transformed cells had weak staining in 10-30%
of the cells.

Relative efficacy of different influenza virus-pulsed APCs
to induce T cell proliferative responses. Enriched populations
of different APCs were pulsed with live influenza virus, and
their ability to stimulate T cell proliferation was assessed. Viruspulsed dendritic cells were 30-50-fold more effective than macrophages and > 200-fold more effective than B cells (Fig. 2).
Influenza-specific responses were detectable even when one
dendritic cell was used per 300 T cells. At these stimulator/
responder ratios, influenza virus-pulsed macrophages and B
cells were unable to induce T cells to proliferate (Fig. 2). We
noted that in cultures containing significant numbers of infected
macrophages, e.g., at T cell/APC ratios of 10:1 or bulk cultures
of PBMCs, there was striking toxicity and death of most cells,
including T cells.
Dendritic cells are potent stimulators for the induction of
influenza-specific killer cell responses. We compared dendritic
cells and macrophages for their capacity to generate human
virus-specific CTL responses. The responding T cells were
extensively depleted of APCs and added at a constant dose of
1 X 106 (see Methods). APCs were then added in graded doses.
In dozens of experiments, the T cells never generated lytic
activity unless APCs were added, and the APCs themselves did
not form lytic cells. Dendritic cells, if infected with influenza
virus, generated significant CTL responses even when used at
a 100:1 T cell/dendritic cell ratio (Fig. 3 A). Significant killing
was seen in the primary effector cell populations even at E/T
ratios of 10:1 (Fig. 3 B) or less (data not shown). In contrast,
macrophages were far less stimulatory, in the order of 100fold or less, possibly due to the significant macrophage death
observed after infection with virus. Since B cells are poor stimulators of the proliferative response to influenza and do not get
infected with the virus (see above), it is unlikely that contaminating B cells in our dendritic cell population account for the
CTL that are generated. OKM1, an mAb directed towards the
CD1 lb antigen, known to remove NK cell precursors (8), was
used to deplete these cells from the starting T cell population.
Thus, the effector cell population used in these assays is composed of T cells. Experiments to be described below showed
the killers to be CD8+CD4-. Most donors, > 90%, could be
stimulated to form CTLs with virus-infected dendritic cells,
indicating that the majority of our donor pool has been exposed
to influenza. Because CTL activity was measured on influenza
A/PR8-infected targets, a strain first identified in 1934, and the
prevalent strains are A/Texas/36/91 and A/Beijing/32/92, the
CTLs generated appear to be cross-reactive, confirming other
studies of human influenza-specific CTLs (18).
Knowing that B cells do not contribute to CTL development,
we next determined whether a partially purified preparation
of dendritic cells (i.e., omitting the metrizamide column for
enrichment) was adequate for generating CTL responses to influenza. ER-, FcR- preparations are depleted of most T cells
and monocytes and consist of 5% dendritic cells, the remaining cells being primarily B cells. At T/APC ratios of 3:1
or 10:1, significant CTL responses were apparent (Fig. 4). This
corresponds to a T/dendritic cell ratio of 60:1 to 180:1. ER-,
FcR- cells were used as stimulators for all subsequent experiments, in T/APC ratios varying from 3:1 to 5:1. These partially
enriched populations (a) suffice to provide the cultures with
dendritic cells in the 0.5-1.5% range, (b) lack inhibitory monocytes, and (c) are straightforward to prepare.
To ascertain when lytic activity was optimal, we measured
CD4-independent Human Antiviral Cytolytic T Lymphocytes
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Figure 1. Following infection with influenza virus, dendritic cells express HA and
NP proteins. (A-E) Dendritic cells were
pulsed with virus for 60 min, washed extensively, and then cultured for 16 h. (F)
Dendritic cells were cultured for 1 h after
the virus pulse. (G and H) Purified monocytes were infected with influenza virus
as above and cultured for 16 h. At the
end of the culture period, cells were collected and cytospins were prepared and
stained with the following panel of mAbs:
(A) Control mAb, anti-CD8 (OKT8).
Black arrows depict contaminating
CD8+ T cells in the APC population. A
white arrow illustrates a negatively
stained dendritic cell. (B) Anti-MHC
class II (9.3C9). The three-headed arrow
identifies typical dendritic cells. (C)
Anti-NP (HB65). The black arrow points
to the intense nuclear location of NP in
a dendritic cell. The white arrow illustrates a negatively stained contaminating
lymphocyte. (D) Anti-HA (H17L2). The
arrow points to a typical dendritic cell.
(E-G) Anti-HA (H28E23). In E, the
arrows identify typical dendritic cells,
with hairy processes as expected for a
plasma membrane envelope protein. In
F, white arrows point to the granular appearance of HA presumably in endosomal
granules; black arrows point to the diffuse
location of HA in a few rapidly infected
dendritic cells. In G, dying infected
monocytes are phagocytosed by noninfected cells (black arrow). (H) Anti-NP
(HB65). NP is detected in several dying
and live monocytes.
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Figure 2. Influenza virus-infected dendritic cells stimulate T cell proliferative responses. Bulk T cells were tested in a standard proliferation
assay for responsiveness to influenza virus-infected and noninfected
dendritic cells, macrophages, and B cells at various T/APC ratios. Cultures were pulsed on day 5 for 9 h with 4 btCi/ml of [3H]TdR. Results
are means of triplicates.
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5% at all stimulator doses and E/T ratios used.

infected dendritic cells for 7 d and then separated the populations into CD4+ and CD8+ subsets. The cultures were stained
with CD4-FITC and CD8-PE mAbs (see Methods) and sorted
on a FACStar into > 98% pure CD4+ and CD8+ populations.
Unseparated as well as sorted cells were then evaluated for lytic
activity. Table I shows the data from three individual experiments. Influenza-specific lytic activity was seen in two populations: bulk T cells and purified CD8+ T cells. CD4+ T cells
failed to demonstrate any lytic activity. In general the CD8+
cells were enriched for lytic activity compared with the bulk T
cells (experiments 1 and 2). FACS analyses of the stimulated
cultures contained many enlarged T blasts and most of the
enlarged cells were CD8+; few CD4+ cells appeared to enlarge
in these cultures (Fig. 6).

CTL development over the course of 9 d. Lytic activity peaked
at day 7 (Fig. 5), consistent with other studies (18) with little
variation from donor to donor. At this time, microscopic examination routinely showed the development of large cell clusters
and released T cell blasts, as is characteristic of dendritic cellmediated T cell responses in vitro (9). Occasionally, assays
were done on day 8 if the clusters seemed slow to develop, and
blast release was delayed.
CD8+ T cells are the principal CTLs induced with infected
dendritic cells. To establish the types of influenza-specific effector cells in our system, we stimulated bulk T cells with
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Figure 4. Partially enriched preparations of dendritic cells suffice as
stimulators of influenza-specific CTL responses. 1 x 106 purified T cells
were cultured with graded doses of uninfected (open symbols) or infected ER-, FcR- cells comprising 5% dendritic cells (closed symbols). Lytic activity was measured on syngeneic targets on day 7 of
culture at E/T ratios of 60:1 and 20:1. Lysis of uninfected target cells
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Figure 3. Dendritic cells are potent stimulators for the induction of
influenza-specific CTL responses. (A) 1 x 106 purified T cells from
buffy coat donors were stimulated with graded doses of uninfected (open
symbols) or influenza virus-infected (closed symbols) dendritic cells or
monocytes. After 7 d, CTL activity was measured using infected syngeneic monocytes as targets at E/T ratio of 40:1. Lysis of uninfected target
cells was < 5% at all doses of stimulators used (not shown). (B) Purified
T cells were cultured with uninfected or infected dendritic cells or
monocytes at T/APC ratios of 30:1 for 7 d. Lytic activity was measured
on syngeneic monocyte targets at various Ef/T ratios, as shown. Lysis

of uninfected target cells was < 5% at all E/T ratios used (not shown).
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Figure 5. Kinetics of CTL development. Purified T cells obtained from
buffy coat donor were stimulated with partially enriched populations
of uninfected (open symbols) or influenza virus-infected (closed symbols) dendritic cells at T/APC ratios of 3:1. Lytic activity was measured
at day 5, 7, or 9 on infected syngeneic monocyte targets. Lysis of
uninfected monocyte targets was < 5% at all time points assayed.
a
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Table I. Influenza Virus-specific CTL in Bulk Cultures Are
CD8+ CD4Percent specific lysis of macrophage targets

Experiment 1

Experiment 2

Infection
of APCs

M4i

MO

Bulk

(-)
Flu

CD4+

CD8+

Responding
T cells

E/T ratio

MO

(-)

M4i

Experiment 3

MO

M4b

Flu

(-)

Flu

0
0

0
25

0
0

0
42

2
9

4
51

(-)
Flu

0
0

0
0

0
0

0
0

4
4

8
9

(-)*
Flu

3
2

7
37

0
0

0
57

3
16

9
54

40:1

40:1

(-)

Flu

50:1

Purified T cells were stimulated with partially enriched populations of
uninfected or influenza virus-infected dendritic cells at T/APC ratios
of 3:1. After 7 d of culture, the T cells were stained with CD4-FITC
and CD8-PE mAbs and sorted on a FACStar Plus. The CD4+ and
CD8+ populations were > 98% pure. Lytic activity of each population
was measured on infected syngeneic monocyte targets. Uninfected dendritic cells failed to stimulate influenza specific CTL. Three individual
experiments are shown. * In experiment 1, the E/T ratio in the CD8+
T cell group was 30:1.

To ascertain whether dendritic cell-induced CD8+, influenza-specific CTLs were class I restricted, we evaluated responses generated in two individuals who differed at class I
loci but shared class II specificities (DRw52, DQw1). Donor A
demonstrated significant lytic activity against syngeneic infected macrophage targets (Fig. 7) but lesser activity against
class I mismatched targets (donor B macrophage targets). Likewise, donor B effector cells lysed syngeneic but not allogeneic
(donor A) targets. The small degree of cross-reactivity seen in
the case of A effectors versus B targets may be due to unspecified but shared class I antigens or, possibly, the development
of CD4+-mediated CTL activity, which has been described in
cloned human populations (31, 32). However, the latter is less
likely given that no CD4+ CTLs are generated in our system
(see below).
Purified CD4+ and CD8+ T cells respond to influenza virus-infected dendritic cells. The observation that few CD4+ T
cells seemed to be undergoing proliferation was surprising,
since their role as helper cells for influenza virus-specific CTL
responses is evident in mouse cultures (26). Also human CD4+
T cell clones with lytic activity have been described (31, 32).
To determine whether CD4+ T cells could respond to influenza
virus-infected APCs, we used cell sorting to purify CD4+ and
CD8+ T cells before T cell stimulation. Bulk, sorted CD4+,
or CD8 + T cells, and a combination of both sorted populations
were tested in a standard proliferation assay for responsiveness
to influenza virus-infected ER-, FcR- cells. All four groups
were able to mount proliferative responses to these APCs (Fig.
8). The most prominent response was demonstrated by the
CD8+ T cells (note the lower background) compared with either
bulk or CD4+ T cells. The extent of these responses were
generally similar at several time points tested.
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When CTL responses from these populations were measured, two striking observations were made. First, sorted CD8+
T cells developed CTL activity without a requirement for CD4+
T cells (Fig. 9). These observations are reminiscent of human
alloreactive responses, in which CD4+ helper cells are not required for the generation of CD8+ CTL if dendritic cells are
the APCs (8). Second, CD4+ T cells also developed lytic activity, but only in the absence of CD8+ T cells. We confirmed
that the sorted populations were > 98% pure at the termination
of the 7-d induction period. Thus, contamination of the CD8+
T cells with CD4+ T cells, or vice versa, does not account for
these results. It is more likely that CD4+ T cells only exhibit
the capacity to become CTLs when few or no CD8+ T cells
are present.

Discussion
Experimental conditions for the generation of human CD8+
CTLs. To generate CD8+ CTLs against infectious agents in
cultures of human T cells, one commonly uses unseparated
populations of PBMCs and/or repeated stimulation in the presence of exogenous lymphokines such as IL-2 (4, 5, 13, 14, 1722). These requirements for CD8+ CTL development stand in
contrast to CD4+ T cell responses, which often are detected

within 3-5 d of culture without exogenous lymphokines. Furthermore, the primary APCs that induce CTL responses in human T cell cultures have not been well characterized. We report
here that strong influenza virus-specific CTLs can be induced
using virus-infected dendritic cells as APCs. Partially enriched
dendritic cells, which are straightforward to isolate, suffice for
the development of CTLs. Our data extend prior reports that
human dendritic cells can induce proliferative T cell responses
to influenza virus (33).
Four features distinguish our system for generating CTLs
from the bulk culture systems that have been used previously.
First, only a few dendritic cells (0.5-1% suffice) are able to
generate highly potent CTL, as demonstrated by the fact that
killing is evident at EIT ratios of 1.5:1 (Fig. 5). Such efficacy
has not been described in CTLs generated from cultures of bulk
PBMCs (13, 14, 18, 21). Second, depletion of monocytes is
necessary to remove potential inhibitory and toxic effects on the
effector cells. In attempts to generate CTLs from unseparated
PBMCs, we often observed significant cell death that prohibited
killer cell development. This was likely secondary to cytopathic
effects of viral infection in monocytes (Fig. 1), as previously
described (34, 35). PBMCs contain about 1% dendritic cells
(36), and an Ia+ cell is known to be required for the generation
of influenza virus-specific CTL in bulk PBMC culture systems
(18). We suggest that these small numbers of dendritic cells are
sufficient to permit CTL development in circumstances where
few monocytes are present or become infected. Third, although
monocytes do not induce CTLs effectively, they serve as efficient targets in short-term chromium-release assays (5 h). During this time interval, a majority of monocytes express viral
proteins as demonstrated by immunohistochemistry (data not
shown). In contrast, standard target cells, e.g., B cell lines or
PHA-treated lymphocytes, have a low level of infection (1030%) and are less efficient in our hands as targets. Fourth,
effector cell populations are routinely depleted of NK cells.
These cells, which are activated by dendritic cells in vitro to
lyse tumor cell targets (8), may play a role in viral clearance.
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Figure 6. CD4/CD8 phenotype in bulk T cell populations responding to influenza virus antigens. Bulk T cells were cultured with uninfected or
infected APCs for 7 d, after which they were phenotyped for CD4 or CD8 expression as described in Methods. Dot plots are of forward versus
side scatter (left), anti-CD4-FITC versus forward scatter (middle) or anti-CD8-PE versus forward scatter (right). Note that the majority of large
cells responding to infected APCs are CD8+. Control mAbs did not stain the T cells (not shown).
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Figure 7. Evidence that human influenza-specific CTL are class I restricted. Donors A and B, who differ at class I but share class II antigens
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cultured with infected or uninfected syngeneic APCs for 7 d, after which
the cells were harvested for CTL activity. Lytic activity was measured
on syngeneic and allogeneic macrophage targets. Uninfected APCs
failed to elicit CTL activity (data not shown).

They are not ordinarily depleted in bulk culture systems and,
therefore, could potentially mask specific CTL measurement.
APC requirements for the generation of influenza virusspecific CTLs. T cell-mediated immunity develops in two
stages. In the afferent phase, dendritic cells bearing antigen
initiate T-dependent responses from resting lymphocytes. Once
activated, the sensitized T lymphoblasts can interact with other
APCs in the efferent phase, to induce a number of effector
functions, e.g., B cell antibody synthesis (37), macrophage activation, and IL-1 production (38). As demonstrated here with
influenza virus, dendritic cells serve in a similar capacity to first
induce the generation of CD8+ CTLs, which then acquire the
ability to kill infected macrophage targets. These pathways for
CTL generation are potentially important for the prevention of
cell-cell spread of virus.
Several features may account for the observed differences
between dendritic cells and monocytes in the induction of influenza-specific CTLs. One appears to be the manner in which
influenza virus infection is handled by these two types of APCs.
Greater than 90% of dendritic cells expressed HA, NP, (Fig. 1)
and NS-1 (not shown) within 16 h and remained fully viable
for > 24 h after infection. In sharp contrast, freshly isolated
monocytes or week-old cultured macrophages were infected to
CD4-independent
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[3H]TdR. Results are means of triplicates ±SD. Note the log scale on
the y-axis.

a lesser extent (< 70%) but died within 16 h of infection (Fig.
1). In addition to influenza virus, dendritic cells are specialized
APCs for the presentation of several other viruses to T cells,
including HSV (30), Moloney leukemia virus (28), Sendai virus
(28) in the mouse, and HIV in humans (39). It is not known
whether the efficacy of dendritic cells in part reflects better
developed pathways for the handling of viral antigens, e.g.,
efficient charging of MHC class I and II molecules. The findings

75.

Bulk T cells

CD4 T cells

nevertheless are consistent with other studies showing that dendritic cells present microbial antigens (M. tuberculosis [40],
Leishmania [41], and staphylococcal enterotoxins [42]) efficiently to T cells.
Dendritic cells are also distinguished from APCs like monocytes and B cells in the efficiency with which they deliver
signals to the TCR-CD3 complex on T cells. For example,
occupancy of only 0.1% of dendritic cell surface class II molecules with superantigen is sufficient to induce T cell proliferation (23). This is due in part to the fact that dendritic cells
express and upregulate many accessory molecules that are critical during the initiation of T cell immune responses (e.g., MLR
[43] and superantigens [23]). They include B7/BB1 (CD80),
ICAM-1 (CD54), and LFA-3 (CD58), ligands for CD28,
CD1 la, and CD2, respectively. Although we have yet to study
the role of these accessory molecules on dendritic cells in CTL
induction, there is evidence that interaction of CD28 with its
ligand is a critical element in the activation of cytotoxic CD8+
T cells (44). For example, murine class I restricted CTLs to
alloantigens can be generated in the absence of help from CD4+
T cells, provided a CD28-B7 interaction occurs in the induction
phase (44). Furthermore, B7-transfected tumor cells can induce
protective (CD8+ T cell-mediated) antitumor responses in vivo
when CD4+ T cells are absent (45, 46). If dendritic cells are
key accessories in CTL induction, one would predict that these
APCs should be effective in the generation of CTL responses
to other antigens (e.g., melanoma antigens, alloantigens) where
B7 is known to amplify the T cell response (43, 45, 46). The
CD28-B7/BB 1 interaction provides a critical costimulatory
mechanism for IL-2 gene expression (47-49). This would explain the CD4 helper independence of CTL induction by dendritic cells, i.e., their ability to present antigen together with
costimulatory molecules like B7/BB 1 that enhance the production of IL-2.
Helper cells are not required for the generation of CD8+
CTLs. Resting human T cells extensively depleted of CD4+
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cells can be induced by dendritic cells to develop influenza
virus-specific cytolytic activity. As in bulk cultures of T cells,
CTL activity is generated with relatively few dendritic cells
(Fig. 9). Dendritic cells also directly induce human and murine
CD8+ T cells to develop cytotoxic activity in the MLR (8, 50).
In contrast to these findings, Nonacs et al. (26) found that mouse
dendritic cells were unable to induce influenza virus-specific
CTL activity in purified CD8+ T cells unless a source of CD4+
T cells or helper lymphokines was available. A key variable
here may be the number of antigen-specific IL-2 producers
in the primed CD8+ population. For example, the paucity of
precursor T cells in the mouse (1:16,600 to 1:2,400 [51]) may
be insufficient to generate enough lymphokine to amplify a CTL
response. Also, far fewer murine dendritic cells (< 20%, [26])
are capable of synthesizing viral proteins than human blood
dendritic cells (> 90%, Fig. 1).
There are now several examples of CTL development in the
apparent absence of CD4 help in vivo. For example, elimination
of CD4+ T cells in mice does not ablate resistance to ectromelia
virus (52), LCMV or vaccinia virus (53), and tumors (45, 46).
Extensive proliferation of CD8+ T cells- in response to influenza virus-infected dendritic cells. The majority of T cells
that proliferate to influenza virus antigens in bulk cultures are
CD8+. We made this observation in routine FACS® analyses
of stimulated cultures (Fig. 6), in which most enlarged T cells
stained with antibodies to CD8. Primary populations of human
CD8+ T cells, depleted of CD4+ T cells, also proliferate extensively after exposure to influenza virus-infected dendritic cells.
The proliferative responses were considerably greater when
compared with bulk or CD4+ T cell responses (Fig. 8). Other
than responses to MLR antigens (8), we are not aware of other
systems where such extensive antigen-dependent CD8 blastogenesis takes place. In mice, after intraperitoneal infection with
LCMV, large increases in CD8+ T cells occur in the spleen as
well as the peritoneum (54).
Influenza virus-specific CD4+ CTL are also generated by
dendritic cells. Highly purified CD4+ cells can be induced by
blood dendritic cells to proliferate and develop cytolytic activity
(Figs. 8 and 9). However, it is necessary to remove the CD8+
T cells to observe both the blastogenesis and CTL responses.
The reasons for this are unclear. We considered the possibility
that, in bulk cultures, CD8+ CTLs might kill the CD4+ cells.
Alternatively, there might be selective inhibition of exogenous
antigen presentation via the class H pathway, as previously
described for influenza virus-infected murine APCs (55). This
seemed unlikely for two reasons. First, CD4+ T cells can respond directly to infected dendritic cells when separated from
CD8+ T cells. Second, influenza virus-infected APCs could
present PPD to M. tuberculosis-reactive CD4+ T cell clones
as well as uninfected APCs (data not shown).
Influenza-specific CD4+ CTL have been described in both
human and mouse systems (16, 31, 32). In contrast to CD8+
CTLs, CD4+ class H-restricted CTLs lysed target cells treated
with noninfectious influenza virus or purified HA preparations
and class II presentation was sensitive to lysosomotropic agents
(16). These differences provided critical early evidence that
MHC class I- and class H-restricted CTL, depended upon
divergent pathways for presentation of antigen. The role of
CD4+ CTL in viral clearance and recovery from infection,
however, remains to be determined. ,6-2-Microglobulin deficient (-/-) mice have few CD8+ T cells but can clear vaccinia

virus and nonlethal HKX31 influenza A virus and resist a low
inoculation dose of PR8 (56), but recovery from lethal doses
of the virulent strain seems to require the presence of CD8+ T
cells (57). In contrast, /8-2-microglobulin deficient (-/-) mice
infected with LCMV intracranially develop CD4+ CTL that
mediate disease, similar to their CD8+ counterparts in infected
normal strains (58).
Potential uses of CD8+ CTLs in influenza prophylaxis and
therapy. Influenza A virus infection remains a major cause of
mortality and morbidity, primarily because the control of the
respiratory illness has not been achieved through vaccination.
Current vaccines are designed to boost antibody responses to
viral antigens (HA and NA) that undergo antigenic drift and
shift (10). Consequently, the protective effects of antibodies
decline with time. Vaccines directed towards the induction of
influenza virus-specific cytotoxic T cell immune responses
might be far more effective, because CTL have been shown to
express cross-reactivity in recognition of subtypes of influenza
A (18). There is evidence in humans that CTL responses play
a role in recovery from infection. McMichael et al. (13) related
levels of CTL immunity to clearance of nasal virus by normal
donors inoculated with live virus. A clear association was observed between CTL responses and clearance of virus.
An ideal vaccine would use cross-reactive antigens, induce
CD8+ CTL responses in most hosts, and have an efficient
means of delivery. Several approaches to induce CTLs with
these properties have been attempted in a number of systems.
They include delivery of class I-restricted peptides with adjuvant (59-62), conjugated to lipid (63), complexed with immune-stimulating complexes (64), or inserted into liposomes
(65, 66). The injection of DNA encoding the immunizing antigen directly into skeletal muscle (67) has also been reported to
induce CTL.
Until recently, dendritic cells have not been directly considered
in strategies to design new vaccines that generate CD8+ CTLs.
Targeting antigen to dendritic cells has several advantages: one
can maximiz the efficiency of T cell activation (9) and avoid
anergy induction (68) or the use of adjuvants (69). For example,
dendritic cells pulsed with antigen in vitro and delivered in vivo
to mice have been highly effective for generating CD4+ immune
responses to protein antigens and microbes (69, 70). Mouse dendritic cells pulsed with class I-restricted peptides of NP (26), HIV
peptides (71), or given antigen via pH-sensitive liposomes (66)
into the cytoplasm can induce CTL responses.
A pivotal role for dendritic cells in human disease prophylaxis and therapy is suggested by their ability to directly induce
strong CD8+ CTL responses, as shown here for influenza virus.
It may be possible to pulse dendritic cells directly with NP
peptides or with attenuated virus, for instance, and use these
APCs in vivo to elicit CTL responses. By adapting the systems
developed in this study, dendritic cells could also be used for
generating large numbers of CD8+ CTL, for adoptive transfer
to immunosuppressed individuals who are unable to mount normal immune responses. Immunotherapy with CD8+ CTL has
been shown to amplify the immune response. Bone marrow
transplant recipients given CMV-specific CTL by adoptive
transfer do not develop disease or viremia (4). These novel
approaches for immunoprophylaxis and therapy should be applicable to several situations where CD8+ CTLs are believed to
play a therapeutic role, e.g., HIV infection (1-3), malaria (5),
and malignancies such as melanoma (6, 7).
CD4-independent Human Antiviral Cytolytic T Lymphocytes

805

Acknowledgments

1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus
protein in association with HLA-A2. Nature (Lond.). 326:881-882.

We thank Dr. J. Yewdell for use of several reagents, Dr. A. Molloy for
advice, S. Gezelter for assistance with sorting, J. Adams for graphics,
and Dr. I. Tang for reviewing the manuscript.
This work was supported by grants from the National Institutes of
Health (AR-39552 to N. Bhardwaj, AI-24775 to R. M. Steinman); the
Irma T. Hirschl Trust (N. Bhardwaj); and the Deutsche Forschungsgemeinschaft (Be 1609/1-1) to A. Bender.

20. McMichael, A. J., F. M. Gotch, and J. Rothbard. 1986. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T
lymphocytes. J. Exp. Med. 164:1397-1406.
21. Sutton, J., S. Rowland-Jones, W. Rosenberg, D. Nixon, F. Gotch, X.-M.
Gao, N. Murray, A. Spoonas, P. Driscoll, M. Smith, et al. 1993. A sequence
pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed
by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447-453.
22. Bowness, P., P. A. H. Moss, J. I. Bell, and A. J. McMichael. 1993.
Conservation of T cell receptor usage by HLA B27-restricted influenza-specific
cytotoxic T lymphocytes suggests a general pattern for antigen-specific major
histocompatibility complex class I-restricted responses. Eur. J.' Immunol.
23:1417-1421.
23. Bhardwaj, N., J. W. Young, A. J. Nisanian, J. Baggers, and R. M.
Steinman. 1993. Small amounts of superantigen, when presented on dendritic
cells, are sufficient to initiate T cell responses. J. Exp. Med. 178:633-642.
24. Young, J. W., and R. M. Steinman. 1988. Accessory cell requirements
for the mixed leukocyte reaction and polyclonal mitogens, as studied with a new
technique for enriching blood dendritic cells. Cell. Immunol. 1 111:167-182.
25. Freudenthal, P. S., and R. M. Steinman. 1990. The distinct surface of
human blood dendritic cells, as observed after an improved isolation method.
Proc. Natl. Acad. Sci. USA. 87:7698-7702.
26. Nonacs, R., C. Humborg, J. P. Tam, and R. M. Steinman. 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenzaspecific, cytolytic T lymphocytes. J. Exp. Med. 176:519-529.
27. Young, J. W., and R. M. Steinman. 1987. Mononuclear phagocytes as
targets for cytolytic T lymphocytes. J. Immunol. Methods. 100:99-105.
28. Kast, W. M., C. J. P. Boog, B. 0. Roep, A. C. Voordouw, and C. J. M.
Melief. 1988. Failure or success in the restoration of virus-specific cytotoxic T
lymphocyte response defects by dendritic cells. J. Immunol. 140:3186-3193.
29. Macatonia, S. E., P. M. Taylor, S. D. Knight, and B. A. Askonas. 1989.
Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic
T cell responses in vitro. J. Exp. Med. 169:1255-1264.
30. Hengel, H., M. Lindner, H. Wagner, and K. Heeg. 1987. Frequency of
herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen-and antigen-driven primary in vitro T cell responses. J. Immunol. 139:41964202.
31. Kaplan, D. R., R. Griffith, V. L. Braciale, and T. J. Braciale. 1984.
Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic
specificity and restriction by class II MHC products. Cell. Immunol. 88:193-206.
32. Cerundolo, V., A. G. D. Tse, R. D. Salter, P. Parham, and A. Townsend.
1991. CD8 independence and specificity of cytotoxic T lymphocytes restricted
by HLA-Aw68.1. Proc. R. Soc. Lond. B. 244:169-177.
33. Knight, S. C., and S. E. Macatonia. 1988. Dendritic cells and viruses.
Immunol. Lett. 19:177-182.
34. Peschke, T., A. Bender, M. Nain, and D. Gemsa. 1993. Role of macrophage
cytokines in influenza A virus infections. Immunobiology 189:340-355.
35. Fesq, H., M. Bacher, M. Nain, and D. Gemsa. 1994. Programmed cell
death (apoptosis) in human monocytes infected by influenza virus. Immunobiology. 190:175-182.
36. O'Doherty, U., R. M. Steinman, M. Peng, P. U. Cameron, S. Gezelter, I.
Kopeloff, W. J. Swiggard, M. Pope, and N. Bhardwaj. 1993. Dendritic cells
freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp.
Med. 178:1067-1078.
37. Inaba, K., and R. M. Steinman. 1985. Protein-specific helper T lymphocyte
formation initiated by dendritic cells. Science (Wash. DC). 229:475-479.
38. Bhardwaj, N., L. L. Lau, S. M. Friedman, M. K. Crow, and R. M. Steinman.
1989. Interleukin 1 production during accessory cell-dependent mitogenesis of T
lymphocytes. J. Exp. Med. 169:1121-1136.
39. Macatonia, S. E., S. Patterson, and S. C. Knight. 1991. Primary proliferative and cytotoxic T cell response to HIV induced in vitro by human dendritic
cells. Immunology 74:399-406.
40. Pancholi, P., R. M. Steinman, and N. Bhardwaj. 1992. Dendritic cells
efficiently immunoselect mycobacterial-reactive T cells in human blood, including
clonable antigen-reactive precursors. Immunology 76:217-224.
41. Moll, H., H. Fuchs, C. Blank, and M. Rollinghoff. 1993. Langerhans cells
transport Leishmania major from the infected skin to the draining lymph node
for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595-1601.
42. Bhardwaj, N., S. M. Friedman, B. C. Cole, and A. J. Nisanian. 1992.
Dendritic cells are potent antigen-presenting cells for microbial superantigens. J.
Exp. Med. 175:267-273.
43. Young, J. W., L. Koulova, S. A. Soergel, E. A. Clark, R. M. Steinman,
and B. Dupont. 1992. The B7/BB 1 antigen provides one of several costimulatory
signals for the activation of CD4+ T lymphocytes by human blood dendritic cells
in vitro. J. Clin. Invest. 90:229-237.
44. Harding, F. A., and J. P. Allison. 1993. CD28-B7 interactions allow the

References
1. Koup, R. A., C. A. Pikora, K. Luzuriaga, D. B. Brettler, E. S. Day, G. P.
Mazzara, and J. L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T
lymphocytes to human immunodeficiency virus gag antigens in infected persons.
In vitro quantitation of effector cell populations with p17 and p24 specificities.
J. Exp. Med. 174:1593-1600.
2. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative
analysis of the human HIV-1 specific cytotoxic T lymphocyte [CTL] response at
different stages of HIV-1 infection. Differential CTL response to HIV-1 and
Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
3. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992.
Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes
in a conserved region of the human immunodeficiency virus type 1 envelope
glycoprotein. Definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
4. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and
P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans
by the adoptive transfer of T cell clones. Science (Wash. DC). 257:238-241.
5. Hill, A. V. S., J. Elvin, A. C. Willis, M. Aidoo, C. E. M. Allsopp, F. M.
Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. M. Townsend, et al.
1992. Molecular analysis of the association of HLA-B53 and resistance to severe
malaria. Nature (Lond.). 360:434-439.
6. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen,
B. Van Den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen
recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash.
DC). 254:1643 -1647.
7. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe', P.
Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized
by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med.

178:489-495.
8. Young, J. W., and R. M. Steinman. 1990. Dendritic cells stimulate primary
human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J.
Exp. Med. 171:1315-1332.
9. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
10. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification
of the antibody-binding sites of Hong Kong influenza haemagglutinin and their
involvement in antigenic variation. Nature (Lond.). 289:373-378.
11. Holt, P. G., M. A. Schon-Hegrad, and J. Oliver. 1987. MHC class H
antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of
antigen presentation activity by endogenous macrophage populations. J. Exp. Med.
167:262-274.
12. Schon-Hegrad, M. A., J. Oliver, P. G. McMenamin, and P. G. Holt. 1991.
Studies on the density, distribution, and surface phenotype of intraepithelial class
II major histocompatability complex antigen [la]-bearing dendritic cells [DC] in
the conducting airways. J. Exp. Med. 173:1345-1356.
13. McMichael, A. J., F. M. Gotch, G. R. Noble, and P. A. S. Beare. 1983.
Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:13-17.
14. Townsend, A. R. M., F. M. Gotch, and J. Davey. 1985. Cytotoxic T cells
recognize fragments of the influenza nucleoprotein. Cell. 42:457-467.
15. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith,
and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized
by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell.
44:959-968.
16. Morrison, L. A., A. E. Lukacher, V. L. Braciale, D. P. Fan, and T. J.
Braciale. 1986. Differences in antigen presentation to MHC class I- and class
II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med.
163:903-921.
17. Carreno, B. M., R. W. Anderson, J. E. Coligan, and W. E. Biddison. 1990.
HLA-B37 and HLA-A2. 1 molecules bind largely nonoverlapping sets of peptides.
Proc. Natl. Acad. Sci. USA. 87:3420-3424.
18. McMichael, A. J., and B. A. Askonas. 1978. Influenza virus-specific
cytotoxic T cells in man: induction and properties of the cytotoxic cell. Eur. J.
Immunol. 8:705-711.
19. Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael.

806

Bhardwaj, Bender, Gonzalez, Bui, Garrett, and Steinman

matrix

induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
J. Exp. Med. 177:1791-1796.
45. Townsend, S. E., and J. P. Allison. 1993. Tumor rejection after direct
costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (Wash.
DC). 259:368-370.
46. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A.
Ledbetter, P. McGowan, and P. S. Linsley. 1992. Costimulation of antitumor
immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and
CTLA-4. Cell. 71:1093-1102.
47. Fraser, J. D., M. E. Newton, and A. Weiss. 1992. CD28 and T cell antigen
receptor signal transduction coordinately regulate interleukin 2 gene expression
in response to superantigen stimulation. J. Exp. Med. 175:1131-1134.
48. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation
of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.
Science (Wash. DC). 251:313-316.
49. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young,
S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway
regulates the production of multiple T cell-derived lymphokines/cytokines. Proc.
Natl. Acad. Sci. USA. 86:1333-1337.
50. Inaba, K., J. W. Young, and R. M. Steinman. 1987. Direct activation of
CD8+ cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-194.
51. Wysocka, M., and J. P. Bennink. 1988. Limiting dilution analysis of
memory cytotoxic T lymphocytes specific for individual influenza virus gene
products. Cell. Immunol. 112:425-429.
52. Buller, M. L., K. L. Holmes, A. Hugin, T. N. Frederickson, and H. C.
Morse III. 1987. Induction of cytotoxic T-cell response in vivo in the absence of
CD4 helper cells. Nature (Lond.). 328:77-79.
53. Rahemtulla, A., W. P. Fung-Leung, M. W. Schilham, T. M. Kundig, S. R.
Sambhara, A. Narendran, A. Arabian, A. Wakeham, C. J. Paige, R. M. Zinkernagel, et al. 1991. Normal development and function of CD8+ cells but markedly
decreased helper cell activity in mice lacking CD4. Nature (Lond.). 353:180184.
54. Lynch, D. H., and R. E. Miller. 1994. Interleukin 7 promotes long-term
in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic
efficacy in vivo. J. Exp. Med. 179:31-42.
55. Domanico, S. Z., and S. K. Pierce. 1992. Virus infection blocks the
processing and presentation of exogenous antigen with the major histocompatibility complex class H molecules. Eur. J. InmnunoL 22:2055-2062.
56. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty.
1991. Clearance of influenza virus respiratory infection in mice lacking class I
major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174:875880.
57. Bender, B. S., T. Croghan, L. Zhang, and P. A. Small, Jr. 1992. Transgenic
mice lacking class I major histocompatibility complex-restricted T cells have

delayed viral clearance and increased mortality after influenza virus challenge. J.
Exp. Med. 175:1143-1145.
58. Muller, D., B. H. Koller, J. L. Whitton, K. E. LaPan, K. K. Brigman, and
J. A. Frelinger. 1992. LCMV-specific, class II-restricted cytotoxic T cells in 62microglobulin-deficient mice. Science (Wash. DC). 255:1576-1578.
59. Kuzu, H., Y. Kuzu, H. Zaghouani, and C. Bona. 1993. In vivo priming
effect during various stages of ontogeny of an influenza A virus nucleoprotein
peptide. Eur. J. Immunol. 23:1397-1400.
60. Aichele, P., H. Hengartner, R. M. Zinkernagel, and M. Schulz. 1990.
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic
peptide. J. Exp. Med. 171:1815-1820.
61. Gao, X.-M., B. Zheng, F. Y. Liew, S. Brett, and J. Tite. 1991. Priming
of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. J. Immunol. 147:3268-3273.
62. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced
antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 88:991993.
63. Deres, K., H. Schild, K.-H. Wiesmuller, G. Jung, and H.-G. Rammensee.
1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic
lipopeptide vaccine. Nature (Lond.). 342:561-564.
64. Takahashi, H., T. Takeshita, B. Morein, S. Putney, R. N. Germain, and
J. A. Berzofsky. 1990. Induction of CD8+ cytotoxic T cells by immunization
with purified HIV-1 envelope protein in ISCOMs. Nature (Lond.). 344:873-875.
65. Watari, E., B. Dietzschold, G. Szokan, and E. Heber-Katz. 1987. A synthetic peptide induces long-term protection from lethal infection with herpes
simplex virus 2. J. Exp. Med. 165:459-470.
66. Nair, S., F. Zhou, R. Reddy, L. Huang, and B. T. Rouse. 1992. Soluble
proteins delivered to dendritic cells via pH-sensitive liposomes induce primary
cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175:609-612.
67. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner,
V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al.
1993. Heterologous protection against influenza by injection of DNA encoding a
viral protein. Science (Wash. DC). 259:1745-1749.
68. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not
memory T cells. Science (Wash. DC). 258:1156-1159.
69. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990.
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific,
MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
70. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman. 1993. Dendritic cell
progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479-

488.
71. Takahashi, H., Y. Nakagawa, K. Yokomuro, and J. A. Berzofsky. 1993.
Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic
irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol.
5:849-857.

CD4-independent Human Antiviral Cytolytic T Lymphocytes

807

